These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study. Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926 [TBL] [Abstract][Full Text] [Related]
10. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310 [TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991 [TBL] [Abstract][Full Text] [Related]
12. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism. Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831 [TBL] [Abstract][Full Text] [Related]
13. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy]. Lass P; Sławek J; Derejko M; Dubaniewicz M Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354 [TBL] [Abstract][Full Text] [Related]
14. Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)? Alster P; Nieciecki M; Koziorowski D; Cacko A; Charzyńska I; Królicki L; Friedman A J Clin Neurosci; 2020 Jul; 77():123-127. PubMed ID: 32389545 [TBL] [Abstract][Full Text] [Related]
15. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606 [TBL] [Abstract][Full Text] [Related]
16. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology; 2000 Nov; 55(10):1540-7. PubMed ID: 11094111 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method]. Kageyama H; Kikuchi S; Tashiro K Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571 [TBL] [Abstract][Full Text] [Related]
19. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066 [TBL] [Abstract][Full Text] [Related]
20. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]